BridgeMD
Acetic Acid in Cutaneous Ulcers. Randomized Controlled Trial.
EU CTIS ID: 2023-504348-32-01
What this study is testing
To study the efficacy of topical treatment with acetic acid versus control to improve healing of skin ulcers with biofilm, in terms of change in ulcer area from baseline (percentage), at 8 weeks of treatment.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients over 18 years of age.
- Continuous care (hospital or outpatient) in one of the study center units.
- Presence of skin ulcer with biofilm, with an area of less than 120 cm2, and in any location (except the facial region).
- Anticipation of treatment and follow-up of the ulcer (at least 8 weeks) at the study center.
- Possibility of collaborating in the necessary evaluations.
- Informed consent for study inclusion, own or by the legal representative of the participant.
You likely can't join if
- Participants diagnosed with any of the following pathologies: a) Ulcers with exposed bone tissue. b) Ulcers of neoplastic origin c) Ulcers older than 18 months
- Participation in another clinical trial that involves an experimental intervention during the period of this trial and/or establishes a periodicity of visits that is incompatible with this trial.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.